Correction: Relative Bioavailability of Dolutegravir (DTG) and Emtricitabine/Tenofovir Alafenamide Fumarate (F/TAF) Administered as Paediatric Tablet Formulations in Healthy Volunteers.

Autor:	Bevers, Lisanne A. H., Kamphuis, Anne E. M., van der Wekken-Pas, L. C. Wendy, Leisegang, Rory, Burger, David M., Colbers, Angela
Předmět:	TENOFOVIR DOLUTEGRAVIR BIOAVAILABILITY EMTRICITABINE VOLUNTEERS PEDIATRICS VOLUNTEER service
Zdroj:	Clinical Pharmacokinetics; May2024, Vol. 63 Issue 5, p729-730, 2p
Abstrakt:	This document is a correction notice for an article titled "Relative Bioavailability of Dolutegravir (DTG) and Emtricitabine/Tenofovir Alafenamide Fumarate (F/TAF) Administered as Paediatric Tablet Formulations in Healthy Volunteers" published in the journal Clinical Pharmacokinetics. The correction addresses an error in Table 1 of the original article, where column headings were incorrect. The corrected table is provided, showing pharmacokinetic parameters for DTG, TAF, TFV, and FTC in different treatments. The original article has been corrected. [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu Full text from SpringerLink